A significant breakthrough in cancer research is occurring with the use of VHH fragments to re-engage mutated p53. This crucial malignant inhibitor protein is frequently lost in various types of cancer, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research